Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
150
天
CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas
作者
Loélia Babin; Elissa Andraos; Steffen Fuchs; Chloe Bessière; Lola Colras; Sandra Dailhau; Cathy Quelen; Cindy Pinto; Iyad Daoudi; Romain Pfeifer; Ahmed Zamani; Marina Bousquet; Stéphane Pyronnet; Christine Gaspin; Laurence Lamant; Fabienne Meggetto展开收起
作者单位
1. Univ Toulouse, CNRS, INSERM, CRCT (Cancer Research Center of Toulouse), UMR-1037, UMR-5071, Institut Universitaire du Cancer, Toulouse, France; 2. Laboratoire d’Excellence Toulouse Cancer-TOUCAN, Toulouse, France; 3. Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin, Corporate Member of Freie Universität Berlin and Humboldt-Universität, Berlin, Germany; 4. German Cancer Consortium (DKTK), Partner Site Berlin, a Partnership Between DKFZ and Charité-Universitätsmedizin, Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany; 5. INRAE, BioinfOmics, GenoToul Bioinformatics Facility, Université de Toulouse, Castanet-Tolosan, Toulouse, France; 6. INRAE, MIAT, Université de Toulouse, Castanet-Tolosan, Toulouse, France展开收起
184
天
MYD88 variants in chronic lymphocytic leukemia exhibit distinct biological behaviors and prognostic implications
作者
Yuting Yan; Yulan Zhou; Weihao Chen; Jun Wang; Tingyu Wang; Ying Yu; Wenjie Xiong; Yujiao Jia; Zhen Yu; Dehui Zou; Gang An; Lugui Qiu; Fei Li; Shuhua Yi展开收起
作者单位
1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; 2. Tianjin Institutes of Health Science, Tianjin, China; 3. Jiangxi Provincial Key Laboratory of Hematological Diseases, Department of Hematology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; 4. Institute of Hematology, Academy of Clinical Medicine of Jiangxi Province, Nanchang, China展开收起
225
天
Small interfering RNA-mediated silencing of mutant NPM1 suppresses acute myeloid leukemia via reversing KAT7 and p300-mediated histone acetylation
作者
Yongqiang Hou; Yunzhi Xing; Chunjie Chen; Dongxue Su; Zhien Zhou; Yi Ye; Zhangjian Lai; Zhixian Peng; Hongxi Cai; Min Sun; Yue Liu; Bingying Yang; Haitao Huang; Zhe Li; Jinhuan Li; Junhong Li; Huan Gao; Jiaxin Li; Hao Zhao; Yiran Shi; Qinghua Chen; Jun Long; Jiong Hu; Dawang Zhou; Lanfen Chen展开收起
作者单位
1. State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiang’an Hospital, Xiang An Biomedicine Laboratory, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China; 2. Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; 3. Shanghai Institute of Hematology Blood & Marrow Transplantation Center, Department of Hematology, Collaborative Innovation Center of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天